Dexrazoxane as a Protective Agent in Anthracycline Treated Breast Cancer
NCT00955890
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
12
Enrollment
OTHER
Sponsor class
Stopped
Enrolled too slow
Conditions
Breast Cancer
Interventions
DRUG:
Dexrazoxane hydrochloride
DRUG:
Dexrazoxane hydrochloride
Sponsor
Fudan University